Inhibition of histone deacetylase 6 (HDAC6) suppresses the growth of AT-rich interaction domain 1 (ARID1A) (a mutated epigenetic regulator) in tumors and modulates the tumor immune microenvironment. The gene discussed is HDAC6; the disease is neoplasm.